Government monitoring supply of each COVID-19 Essential Drug

Minister of State Shri Mansukh Mandaviya today assured that the Government is monitoring supply of each COVID-19 Essential Drug. All drugs used in the management of COVID-19 are now available in India by ramping up production and increasing the imports. The availability of these drugs is being monitored by implementing three-pronged strategy of Supply Chain Management, Demand Side Management and Affordability.

Protocol Drugs:

  1. Remdesivir
  2. Enoxaparin
  3. MethylPrednisolone
  4. Dexamethasone
  5. Tocilizumab
  6. Ivermectin

Non-protocol Drugs:

  1. Favipiravir
  2. Amphotericin
  3. Apixaban

CDSCO and NPPA are coordinating with manufacturers to enhance production and getting data about current stock, current capacities, Projected production for the May, 2021.

  1. Remdesivir:
  1. Toscilizumab injection:
  1. Dexamethasone 0.5 mg tablets:
  1.  Dexamethasone Injection production ramped up almost 2 times.
  2. Enoxaparin Injection production increased 4 times in mere one month.
  3.  Methyl Prednisolone Injection:
  1. Ivermectin 12 mg tab production enhanced in the country by ~5 times within a month from 150 lakhs in April to 770 lakhs in May,2021.
  2. Favirpiravir:
  1. Amphoterecin B Injection:

Click here for ppt on allocation of drugs:

MC/KP/AK
(Release ID: 1719867)

Read this release in: Urdu Marathi Hindi Bengali Punjabi Gujarati Odia Tamil Kannada Malayalam

Share this:

Exit mobile version